Curanex Pharmaceuticals Inc. is a developmental stage biotechnology company focused on the discovery, development, and commercialization of innovative botanical drugs. Its primary mission is to address significant unmet medical needs by leveraging natural substances, aiming to improve the lives of patients with immune and inflammatory diseases. The company dedicates its research to creating botanical medicines that may offer therapeutic benefits in fields such as autoimmune conditions, metabolic disorders, and viral infections. Founded in 2018 and headquartered in Jericho, New York, Curanex plays a specialized role within the healthcare sector by targeting novel approaches in the biotechnology industry. Through its developmental pipeline, Curanex seeks to expand therapeutic options where conventional pharmaceuticals may be insufficient, positioning itself at the intersection of natural product research and modern drug development. The company operates in a market environment that values innovation for difficult-to-treat medical conditions, reflecting its commitment to both clinical advancement and addressing gaps in standard care.